Stifel Financial’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
256,092
+68,833
| +37% | +$348K | ﹤0.01% | 2151 |
|
|
2025
Q1 | $991K | Buy |
187,259
+27,372
| +17% | +$145K | ﹤0.01% | 2239 |
|
|
2024
Q4 | $1.08M | Sell |
159,887
-2,091
| -1% | -$14.1K | ﹤0.01% | 2199 |
|
|
2024
Q3 | $1.07M | Buy |
161,978
+53,103
| +49% | +$350K | ﹤0.01% | 2186 |
|
|
2024
Q2 | $817K | Buy |
108,875
+64,466
| +145% | +$484K | ﹤0.01% | 2309 |
|
|
2024
Q1 | $443K | Buy |
44,409
+17,220
| +63% | +$172K | ﹤0.01% | 2688 |
|
|
2023
Q4 | $268K | Buy |
+27,189
| New | +$268K | ﹤0.01% | 2907 |
|